Abigail Shockley, PharmD Chimeric antigen receptor T (CAR-T) therapies have resulted in durable remissions for patients with refractory hematologic malignancies; however, patients can experience many side effects following administration. Cytokine…
Megan B. May, PharmD, BCOP, and Tori A. Gray, PharmD Candidate 2022 Non-small cell lung cancer (NSCLC) is the third most common type of cancer in the Unites States (US).…
Fatima Khan, PharmD, and Ila M. Saunders, PharmD, BCOP Chronic graft-vs-host disease (cGVHD) is one of most common, yet severe, consequences of allogeneic hematopoietic stem cell transplantation. Occurring in up…
Elizabeth S. Waxman, BSN, RN, MSN, ANP-BC Hemophagocytic lymphohistiocytosis (HLH) is a rare, potentially fatal syndrome characterized by unchecked and persistent activation of cytotoxic T cells and natural killer (NK)…
Beth Sandy, MSN, CRNP As a nurse practitioner working in thoracic medical oncology, I have seen the changes in non-small cell lung cancer (NSCLC) change dramatically over the past 20…
Samantha Musson, PharmD & Moe Schwartz, PharmD, BCOP The term “targeted therapy” in cancer refers to drugs or treatment strategies that direct anticancer treatment to specific genes or proteins that…
Background and History Biological products or biologics are typically large, complex molecules made within a living system, such as an animal cell. Biologics are used to diagnose, prevent, treat, and…
Multiple myeloma (MM) is a neoplasm characterized by the clonal proliferation of plasma cells that remains an incurable disease. The treatment of relapsed or relapsed/refractory MM continues to be a…
Marissa Duco, PharmD | Dec 13, 2021 10:11:28 AM Immunoglobulin light-chain (AL) amyloidosis is a malignancy of the plasma cells which express CD38 and produce misfolded proteins that lead to organ…
Christina Bartholomew | Dec 13, 2021 10:46:21 AM Although treatment strategies for patients with metastatic gastric cancer who have failed prior lines of therapy remain limited, novel agents such as trastuzumab…